Seth H. Z. Fischer
CIK 1573553 · Chief Executive Officer · last filed 2026-07-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
8
Total Filings
51
Lifetime Open-Market Net
-$43.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ESPR | Director | 0 | $3.18 | $0 | $0 | 7 | 2026-07-13 |
| MIST | Director | — | $1.07 | — | $0 | 5 | 2026-06-12 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Director | 0 | $0.55 | $0 | -$6.7K | 11 | 2025-02-11 |
| SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Director | 0 | $1.03 | $0 | -$55.4K | 6 | 2023-08-01 |
| AGILE THERAPEUTICS INC (AGRX) Delisted | Director | 976 | $1.51 | $1.5K | $0 | 8 | 2023-06-09 |
| Streamex Corp. (BSGM) Delisted | Director | 6,000 | $6.35 | $38.1K | $0 | 1 | 2018-11-09 |
| VIVUS INC (VVUS) Delisted | Chief Executive Officer | 63,398 | — | — | $18.7K | 9 | 2018-01-03 |
| Trius Therapeutics Inc (TSRX) Delisted | Director | — | — | — | $0 | 2 | 2013-05-23 |
Recent Filings · Page 3 of 6
51 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-10 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | +670 | $0 | EDGAR |
| 2022-05-27 | ESPR | Grant (A) | — | $0 | EDGAR |
| 2022-02-07 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | +2,750 | $0 | EDGAR |
| 2021-11-01 | ESPR | — | — | $0 | EDGAR |
| 2021-06-22 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Mixed | +2,277 | -$50.9K | EDGAR |
| 2021-06-10 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | +24,510 | $0 | EDGAR |
| 2021-01-19 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-19 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +30,000 | $0 | EDGAR |
| 2020-06-11 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | +13,393 | $0 | EDGAR |
| 2020-04-27 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +2,500 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.